Date: 12 Mar 2021

Here’s the Official Trailer for Part 2 of our Special Episode of Dialogues on AI Digital Pathology, which is coming up in a week! Listen to these sound bites from our guest KOL liver pathologists, Professor Pierre Bedossa, Professor Zachary Goodman, and Professor David Kleiner as they speak to our Moderator, Dr Nikolai Naoumov about AI digital pathology as a complementary tool for pathologists in interpreting the disease biology of NASH. 

This is a continuation from Part 1, where the KOLs commented on the key takeaways from the recent FDA webcast on NASH Drug Development, and questions from the industry on designing clinical trial strategies with AI digital pathology. Do listen to their conversation in Part 1 if you haven’t!

Guests

Prof. Pierre Bedossa, Professor of Pathology at the University of Paris; Consultant in Liver Pathology at LIVERPAT, Paris, France.

Prof. Zachary Goodman, Director of Hepatic Pathology Consultation and Research, Inova Fairfax Hospital, Falls Church, Virginia, USA.

Prof. David Kleiner, Senior Research Physician and Chief of Post-mortem Section, Laboratory of Pathology, Center for Cancer Research,

National Cancer Institute, Bethesda, Maryland, USA.

Moderator

Dr. Nikolai Naoumov, Adviser for Clinical Research and Drug Development in Liver Diseases, Novartis Pharma AG